{
    "2020-08-03": [
        [
            {
                "time": "",
                "original_text": "智飞生物上半年净利润增超三成",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利润",
                        "增长",
                        "三成"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“重庆股王”智飞生物上半年净利润增长31%，市值站上3000亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利润",
                        "增长",
                        "31%",
                        "市值",
                        "3000亿元"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生猛的智飞生物：半年营收增长38.80%，已自建疫苗冷链并涉足治疗性生物制品",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "营收",
                        "增长",
                        "38.80%",
                        "疫苗冷链",
                        "治疗性生物制品"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【华西医药崔文亮团队】《智飞生物点评报告：Q2业绩超预期，新冠疫苗市场潜力巨大》",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "Q2业绩",
                        "超预期",
                        "新冠疫苗",
                        "市场潜力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：第三轮集采正式启动 疫苗关注度有望持续",
                "features": {
                    "keywords": [
                        "医药生物",
                        "第三轮集采",
                        "启动",
                        "疫苗",
                        "关注度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上周融资余额13720.11亿元，环比增加308.33亿元，复星医药、智飞生物净买入金额超10亿",
                "features": {
                    "keywords": [
                        "融资余额",
                        "环比增加",
                        "复星医药",
                        "智飞生物",
                        "净买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}